Global IL-17 Biologics Research Report 2023-2030: A $4.37 :

Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The

Related Keywords

China , Australia , France , Japan , Germany , Canada , United States , Dublin , Ireland , United Kingdom , Spain , Cosentyx Secukinumab , Eli Lilly , Novartis , National Stem Cell Foundation , Market Share Of Leading Companies , Analysis By Indication , Market Insights , Market Value , Market Assessment , Macro Economic Factors , Market Size , Market Segmentation , Psoriatic Arthritis , Ankylosing Spondylitis , Research And Markets , Antibodies , Antibody Humanization , Biologic , Biopharmaceuticals , Monoclonal , Monoclonal Antibodies , Monoclonal Antibody ,